Study of MGTA-145 and Plerixafor in Patients With Sickle Cell Disease
Clinical trial NCT05445128 · TERMINATED
Trial details
- NCT number
- NCT05445128
- Sponsor
- Ensoma
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-24
- Primary completion
- 2022-12-08
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.